Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001358933 | SCV001554790 | uncertain significance | not provided | 2021-12-24 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the CNGB1 mRNA. The next in-frame methionine is located at codon 21. This variant is present in population databases (rs745636376, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with CNGB1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1050960). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001358933 | SCV001953554 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001358933 | SCV001968865 | pathogenic | not provided | no assertion criteria provided | clinical testing |